Literature DB >> 2843630

Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.

L A Dykstra1, C A Massie.   

Abstract

The effects of several mu and kappa opioid agonists were examined alone and in combination with the opioid antagonist quadazocine in squirrel monkeys responding under a schedule of shock titration. Under this procedure, shock was scheduled to increase once every 15 sec from 0.01 to 2.0 mA in 30 steps. Five responses on a lever during the 15-sec shock period terminated the shock for 15 sec, after which the shock resumed at the next lower intensity. The intensity below which the monkeys maintained the shock 50% of the time (median shock level) and the rate of responding in the presence of shock were determined under control conditions and after administration of the mu agonists, l-methadone and fentanyl and the kappa agonists, bremazocine, ethylketocyclazocine, ketocyclazocine and U50,488. When examined alone, intermediate doses of mu and kappa agonists increased median shock level. At the highest doses of these compounds responding was eliminated and shock rose to its peak intensity. When the mu and kappa agonists were examined in combination with quadazocine, dose-effect curves for median shock level and for rate of responding were shifted to the right in a dose-dependent fashion. A comparison of the pA2 values for quadazocine on median shock level and on rate of responding revealed similar values for the two measures; however, pA2 values differed depending on the agonist examined. That is, the pA2 values for quadazocine in combination with l-methadone and fentanyl on median shock level were 7.43 and 7.61, respectively; whereas the pA2 value for quadazocine in combination with bremazocine and U50,488 were 6.53 and 6.43, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843630

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.

Authors:  M C Ko; E R Butelman; J R Traynor; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

2.  Antinociceptive effects of the kappa opioid, U50,488: lack of modulation by 5-HT2 antagonists.

Authors:  L A Dykstra; K R Powell; Y P Lin
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.

Authors:  M J Picker; S S Negus; K R Powell
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.

Authors:  K R Powell; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

5.  A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in male cynomolgus monkeys.

Authors:  Marc J Kaufman; Amy C Janes; Blaise deB Frederick; Melanie Brimson-Théberge; Yunjie Tong; Samuel B McWilliams; Ashley Bear; Timothy E Gillis; Katrina M Schrode; Perry F Renshaw; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2013-06-17       Impact factor: 3.157

6.  Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.

Authors:  Caren L Steinmiller; Alice M Young
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

7.  Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat.

Authors:  M Ohno; T Yamamoto; S Ueki
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.

Authors:  S Stevens Negus; Ember M Morrissey; Marisa Rosenberg; K Cheng; Kenner C Rice
Journal:  Psychopharmacology (Berl)       Date:  2010-01-26       Impact factor: 4.530

9.  Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.

Authors:  S S Negus; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.